ID RON_HUMAN STANDARD; PRT; 1400 AA. AC Q04912; DT 01-OCT-1994 (REL. 30, CREATED) DT 01-OCT-1994 (REL. 30, LAST SEQUENCE UPDATE) DT 01-NOV-1997 (REL. 35, LAST ANNOTATION UPDATE) DE MACROPHAGE-STIMULATING PROTEIN RECEPTOR PRECURSOR (EC 2.7.1.112) DE (MSP RECEPTOR) (P185-RON) (CD136 ANTIGEN). GN MST1R OR RON. OS HOMO SAPIENS (HUMAN). OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; MAMMALIA; OC EUTHERIA; PRIMATES. RN [1] RP SEQUENCE FROM N.A. RC TISSUE=KERATINOCYTES; RX MEDLINE; 93241719. RA RONSIN C., MUSCATELLI F., MATTEI M.-G., BREATHNACH R.; RL ONCOGENE 8:1195-1202(1993). RN [2] RP SEQUENCE FROM N.A., AND ALTERNATIVE SPLICING. RX MEDLINE; 96413302. RA COLLESI C., SANTORO M.M., GAUDINO G., COMOGLIO P.M.; RL MOL. CELL. BIOL. 16:5518-5526(1996). RN [3] RP FUNCTION. RX MEDLINE; 95025877. RA WANG M.-H., RONSIN C., GESNEL M.-C., COUPEY L., SKEEL A., RA LEONARD E.J., BREATNACH R.; RL SCIENCE 266:117-119(1994). CC -!- FUNCTION: RECEPTOR FOR MACROPHAGE STIMULATING PROTEIN (MSP). HAS A CC TYROSINE-PROTEIN KINASE ACTIVITY. CC -!- CATALYTIC ACTIVITY: ATP + A PROTEIN TYROSINE = ADP + CC PROTEIN TYROSINE PHOSPHATE. CC -!- SUBUNIT: HETERODIMER FORMED OF AN ALPHA CHAIN AND A BETA CC CHAIN WHICH ARE DISULFIDE LINKED. CC -!- SUBCELLULAR LOCATION: TYPE I MEMBRANE PROTEIN. CC -!- TISSUE SPECIFICITY: KERATINOCYTES, AND LUNG. CC -!- PTM: THE TWO SUBUNITS ARE PROTEOLYTICALLY DERIVED. CC -!- PTM: PHOSPHORYLATED IN RESPONSE TO LIGAND BINDING (PROBABLE). CC -!- ALTERNATIVE PRODUCTS: AN ALTERNATIVELY SPLICED FORM FOUND IN A CC GASTRIC CANCER CELL LINE AND CALLED DELTA-RON, LACKS PART OF THE CC EXTRACELLULAR DOMAIN, OLIGOMERIZE AND IS CONSTITUTIVELY ACTIVATED. CC -!- SIMILARITY: BELONGS TO THE MET TYROSINE KINASE FAMILY OF RECEPTOR. CC -!- DATABASE: NAME=PROW; NOTE=CD guide CDw136 entry; CC WWW="http://www.ncbi.nlm.nih.gov/prow/cd/cdw136.htm". CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X70040; G36110; -. DR PIR; S31736; S31736. DR MIM; 600168; -. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. KW TRANSFERASE; TYROSINE-PROTEIN KINASE; RECEPTOR; TRANSMEMBRANE; KW GLYCOPROTEIN; SIGNAL; PHOSPHORYLATION; ATP-BINDING; POLYMORPHISM; KW ALTERNATIVE SPLICING. FT SIGNAL 1 24 POTENTIAL. FT CHAIN 25 1400 MACROPHAGE-STIMULATING PROTEIN RECEPTOR. FT CHAIN 25 304 MSP RECEPTOR ALPHA CHAIN (POTENTIAL). FT CHAIN 310 1400 MSP RECEPTOR BETA CHAIN (POTENTIAL). FT DOMAIN 25 957 EXTRACELLULAR (POTENTIAL). FT TRANSMEM 958 982 POTENTIAL. FT DOMAIN 983 1400 CYTOPLASMIC (POTENTIAL). FT DOMAIN 1082 1345 PROTEIN KINASE. FT NP_BIND 1088 1096 ATP (BY SIMILARITY). FT BINDING 1114 1114 ATP (BY SIMILARITY). FT ACT_SITE 1208 1208 BY SIMILARITY. FT MOD_RES 1353 1353 PHOSPHORYLATION (AUTO-) (BY SIMILARITY). FT MOD_RES 1360 1360 PHOSPHORYLATION (AUTO-) (BY SIMILARITY). FT CARBOHYD 66 66 POTENTIAL. FT CARBOHYD 419 419 POTENTIAL. FT CARBOHYD 458 458 POTENTIAL. FT CARBOHYD 488 488 POTENTIAL. FT CARBOHYD 654 654 POTENTIAL. FT CARBOHYD 720 720 POTENTIAL. FT CARBOHYD 841 841 POTENTIAL. FT CARBOHYD 897 897 POTENTIAL. FT VARSPLIC ? ? MISSING (IN DELTA-RON). FT VARIANT 322 322 Q -> R. SQ SEQUENCE 1400 AA; 152227 MW; E122777A CRC32; MELLPPLPQS FLLLLLLPAK PAAGEDWQCP RTPYAASRDF DVKYVVPSFS AGGLVQAMVT YEGDRNESAV FVAIRNRLHV LGPDLKSVQS LATGPAGDPG CQTCAACGPG PHGPPGDTDT KVLVLDPALP ALVSCGSSLQ GRCFLHDLEP QGTAVHLAAP ACLFSAHHNR PDDCPDCVAS PLGTRVTVVE QGQASYFYVA SSLDAAVAGS FSPRSVSIRR LKADASGFAP GFVALSVLPK HLVSYSIEYV HSFHTGAFVY FLTVQPASVT DDPSALHTRL ARLSATEPEL GDYRELVLDC RFAPKRRRRG APEGGQPYPV LQVAHSAPVG AQLATELSIA EGQEVLFGVF VTGKDGGPGV GPNSVVCAFP IDLLDTLIDE GVERCCESPV HPGLRRGLDF FQSPSFCPNP PGLEALSPNT SCRHFPLLVS SSFSRVDLFN GLLGPVQVTA LYVTRLDNVT VAHMGTMDGR ILQVELVRSL NYLLYVSNFS LGDSGQPVQR DVSRLGDHLL FASGDQVFQV PIRGPGCRHF LTCGRCLRAW HFMGCGWCGN MCGQQKECPG SWQQDHCPPK LTEFHPHSGP LRGSTRLTLC GSNFYLHPSG LVPEGTHQVT VGQSPCRPLP KDSSKLRPVP RKDFVEEFEC ELEPLGTQAV GPTNVSLTVT NMPPGKHFRV DGTSVLRGFS FMEPVLIAVQ PLFGPRAGGT CLTLEGQSLS VGTSRAVLVN GTECLLARVS EGQLLCATPP GATVASVPLS LQVGGAQVPG SWTFQYREDP VVLSISPNCG YINSHITICG QHLTSAWHLV LSFHDGLRAV ESRCERQLPE QQLCRLPEYV VRDPQGWVAG NLSARGDGAA GFTLPGFRFL PPPHPPSANL VPLKPEEHAI KFEYIGLGAV ADCVGINVTV GGESCQHEFR GDMVVCPLPP SLQLGQDGAP LQVCVDGECH ILGRVVRPGP DGVPQSTLLG ILLPLLLLVA ALATALVFSY WWRRKQLVLP PNLNDLASLD QTAGATPLPI LYSGSDYRSG LALPAIDGLD STTCVHGASF SDSEDESCVP LLRKESIQLR DLDSALLAEV KDVLIPHERV VTHSDRVIGK GHFGVVYHGE YIDQAQNRIQ CAIKSLSRIT EMQQVEAFLR EGLLMRGLNH PNVLALIGIM LPPEGLPHVL LPYMCHGDLL QFIRSPQRNP TVKDLISFGL QVARGMEYLA EQKFVHRDLA ARNCMLDESF TVKVADFGLA RDILDREYYS VQQHRHARLP VKWMALESLQ TYRFTTKSDV WSFGVLLWEL LTRGAPPYRH IDPFDLTHFL AQGRRLPQPE YCPDSLYQVM QQCWEADPAV RPTFRVLVGE VEQIVSALLG DHYVQLPATY MNLGPSTSHE MNVRPEQPQF SPMPGNVRRP RPLSEPPRPT //